The decrease of mean platelet volume after extracorporeal LDL-cholesterol elimination

Atherosclerosis Supplements

Volumn 14, Issue 1, 2013, Pages 77-81

  Blaha, M ^a   Kostal, M ^a   Lanska, M ^a   Blaha, V ^a   Foralova, I ^a   Filip, S ^a   Kubisova, M ^a   Maly, J ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Extracorporeal elimination; Familial hyperlipoproteinemia; LDL apheresis; Mean platelet volume; Rheohemapheresis; Therapeutic hemapheresis

Indexed keywords

ATORVASTATIN; EZETIMIBE; FENOFIBRATE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; RESIN; ROSUVASTATIN; SIMVASTATIN;

ADULT; AGE DISTRIBUTION; APHERESIS; ARTICLE; CENTRIFUGATION; CLINICAL ARTICLE; CLINICAL ASSESSMENT; DRUG MEGADOSE; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; HUMAN; IMMUNOADSORPTION; LONG TERM CARE; MALE; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION; SEX DIFFERENCE; STATISTICAL SIGNIFICANCE; THROMBOCYTE COUNT; THROMBOCYTE VOLUME; TREATMENT DURATION;

ADULT; BIOLOGICAL MARKERS; BLOOD COMPONENT REMOVAL; BLOOD PLATELETS; CELL SIZE; CHOLESTEROL, LDL; FEMALE; HUMANS; HYPERLIPOPROTEINEMIA TYPE II; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84872851182     PISSN: 15675688     EISSN: 18785050     Source Type: Journal    
DOI: 10.1016/j.atherosclerosissup.2012.10.019     Document Type: Article

References (26)

1. Stoffel W., Borberg H., Grepe V. Application of specific extracorporeal removal of low density lipoprotein in familial hypercholesterolemia. Lancet 1981, 318:1005-1007.
2. Borberg H. 28 years of LDL-apheresis: a review of experience. Transfus Apher Sci 2009, 41(1):49-59.
3. Bláha M., Krejsek J., Bláha V., et al. Selectins and monocyte chemotactic peptide as the markers of atherosclerosis activity. Physiol Res 2004, 53(3):273-278.
4. Blaha M., Cermanova M., Blaha V., et al. Elevated serum soluble endoglin (sCD105) decreased during extracorporeal elimination therapy for familial hypercholesterolemia. Atherosclerosis 2008, 197(1):264-270.
5. Blazek M., Blaha M., Pecka M., Blaha V., Masin V., Maly J. Primary hemostasis in patients treated with LDL-apheresis for severe familiar hypercholesterolemia: a prospective pilot trial using PFA-100 analysis to rationalize therapeutic LDL-apheresis procedure. Hematology 2007, 12(6):571-576.
6. Chu S.G., Becker R.C., Berger P.B., et al. Mean platelet volume as a predictor of cardiovascular risk: a systematic review and meta-analysis. J Thromb Haemost 2010, 8(1):148-156.
7. Giles H., Smith R.E., Martin J.F. Platelet glycoprotein IIb-IIIa and size are increased in acute myocardial infarction. Eur J Clin Invest 1994, 24:69-72.
8. Kamath S., Blann A.D. Platelet activation: assessment and quantification. Eur Heart J 2001, 22:1561-1571.
9. Jakubowski J.A., Adler B., Thompson C.B., Valeri C.R., Deykin D. Influence of platelet volume on the ability of prostacyclin to inhibit platelet aggregation and the release reaction. J Lab Clin Med 1985, 105(2):271-276.
10. Martin J.F., Shaw T., Heggie J., Penington D.G. Measurement of the density of human platelets and its relationship to volume. Br J Haematol 1983, 54(3):337-352.
11. Guthikonda S., Alviar C.L., Vaduganathan M., et al. Role of reticulated platelets and platelet size heterogeneity on platelet activity after dual antiplatelet therapy with aspirin and clopidogrel in patients with stable coronary artery disease. J Am Coll Cardiol 2008, 52(9):743-749.
12. Pons I., Monteagudo M., Lucchetti G., et al. Correlation between immature platelet fraction and reticulated platelets. Usefulness in the etiology diagnosis of thrombocytopenia. Eur J Haematol 2010, 85(2):158-163.
13. Bröijersen A., Eriksson M., Larsson P.T., Beck O., Berglund L., Angelin B., et al. Effects of selective LDL-apheresis and pravastatin therapy on platelet function in familial hypercholesterolaemia. Eur J Clin Invest 1994, 24(7):488-498.
14. Coban E., Afacan B. The effect of rosuvastatin treatment on the mean platelet volume in patients with uncontrolled primary dyslipidemia with hypolipidemic diet treatment. Platelets 2008, 19(2):111-114.
15. Williams R.R., Hunt S.C., Schumacher M.C., et al. Diagnosing heterozygous familial hypercholesterolemia using new practical criteria validated by molecular genetics. Am J Cardiol 1993, 72:171-176.
16. Šamánek M., Urbanová Z. Cholesterol and triglyceride levels and their development. čas Lék čes 1997, 136:380-385.
17. Latger-Cannard V., Hoarau M., Salignac S., Baumgart D., Nurden P., Lecompte T. Mean platelet volume: comparison of three analysers towards standardization of platelet morphological phenotype. Int J Lab Hematol 2012 Jun, 34(3):300-310.
18. Pathansali R., Smith N., Bath P. Altered megakaryocyte-platelet haemostatic axis in hypercholesterolaemia. Platelets 2001, 12(5):292-297.
19. Tavil Y., Sen N., Yazici H.U., Hizal F., Abaci A., Cengel A. Mean platelet volume in patients with metabolic syndrome and its relationship with coronary artery disease. Thromb Res 2007, 120(2):245-250.
20. Varol E., Icli A., Kocyigit S., Erdogan D., Ozaydin M., Dogan A. Effect of smoking cessation on mean platelet volume. Clin Appl Thromb Hemost 2012 Febr. 12.
21. Bilici S., Sekmenli T., Göksu M., Melek M., Avci V. Mean platelet volume in diagnosis of acute appendicitis in children. Afr Health Sci 2011, 11(3):427-432.
22. Lippi G., Meschi T., Borghi L. Mean platelet volume increases with aging in a large population study. Thromb Res 2012, 18.
23. Ozaydin E., Arhan E., Cetinkaya B., Ozdel S., Deĝerliyurt A., Güven A., et al. Differences in iron deficiency anemia and mean platelet volume between children with simple and complex febrile seizures. Seizure 2012 Apr, 21(3):211-214.
24. Mutlu H., Berk V., Karaca H., Erden A., Aslan T., Akca Z. Treatment regimen with bevacizumab decreases mean platelet volume in patients with metastatic colon cancer. Clin Appl Thromb Hemost 2012 Sep, 18(5):546-548.
25. Mutlu H., Artis T.A., Erden A., Akca Z. Alteration in mean platelet volume and platicrit values in patients with cancer that developed thrombosis. Clin Appl Thromb Hemost 2012 Feb 16, [Epub ahead of print].
26. Vizioli L., Muscari S., Muscari A. The relationship of mean platelet volume with the risk and prognosis of cardiovascular diseases. Int J Clin Pract 2009, 63(10):1509-1515.